T 1053/21 (ZS PHARMA / ZIRCONIUM SILICATE / HYPERKALEMIA) of 04.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T105321.20240404
- Date of decision
- 4 April 2024
- Case number
- T 1053/21
- Online on
- 20 June 2024
- Petition for review of
- -
- Application number
- 12744254.9
- IPC class
- A61K 45/06C07F 7/02A61K 33/24B01J 19/18A61K 33/00A61K 9/14C01B 39/46C01B 39/02B01J 39/14B01J 19/00C01B 33/20B01J 39/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF A ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
- Applicant name
- ZS Pharma, Inc
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Galenicum Health S.L.U.
Sandoz AG - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56
- Keywords
- Amendments - added subject-matter (no)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 13 of the main request filed as auxiliary request 2 with the reply to the appeal, and the description and drawings to be possibly adapted thereto.